Browse > Article
http://dx.doi.org/10.5352/JLS.2012.22.3.398

Polygenic Association of ACE and ACTN3 Polymorphisms with Korean Power Performance  

Kim, Chul-Hyun (Exercise Sport Science Institute, Korea National Sport University)
Publication Information
Journal of Life Science / v.22, no.3, 2012 , pp. 398-406 More about this Journal
Abstract
This study aimed to examine whether the polygenic profile of ACE ID and ACTN3 R577X polymorphisms is associated with muscle power performance in Korean athletes. For this study, 106 top-class power athletes (top-class group), 158 elite power athletes (elite-class group), and 676 healthy adults (control) aged 18-39 yrs were recruited and their genotypes were analyzed. The top-class group showed higher frequencies of the II genotype and I allele in ACE, as well as higher frequencies of the RR genotype and R allele in ACTN3 (top-class vs. control: 41.4% vs. 32.1% for II genotype, 67.1% vs. 57.7% for I allele, p<0.05; 42.3% vs. 29.0% for RR genotype, 65.3% vs. 54.8% for I allele, p<0.05). In the polygenic profile, the top-class group had significantly higher frequencies of combined-II/ID+RR/RX genotype than the control group (top-class vs. control: 82.9% vs. 66.7% for II/ID+RR/RX, p<0.05), and there was even a sharp increase in total genotype score (TGS) in this group compared to the elite-class and control groups ($66{\pm}0.9$ vs. $58{\pm}1.9$ vs. $56{\pm}2.3$, p<0.05). The combined-II/ID+RR/RX genotype showed the possibility of succussion in the top-class muscle power performance with an odds ratio of 2.3 (CI:1.4-4.1, p<0.05). These results suggested that ACE and ACTN3 need to interact with each other to affect muscle-power performance in an additive form. Furthermore, the polygenic profile of ACE and ACTN3 can predict muscle performance with high success in a homogeneous dominant combined genotype (II/ID+RR/RX). A further study could identify and combine other genes into ACE and ACTN3 for muscle strength.
Keywords
Muscle power; genetic traits; ${\alpha}$-actinin-3; angiotensin-converting enzyme;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Yang, N., MacArthur, D. G., Gulbin, J. P., Hahn, A. G., Beggs, A. H., Easteal, S. and North, K. 2003. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet. 73, 627-631.   DOI   ScienceOn
2 Yang, N., Schindeler, A., McDonald, M. M., Seto, J. T., Houweling, P. J., Lek, M. Hogarth, M., Morse, A. R., Raftery, J. M. Balasuriya, D., MacArthur, D. G., Berman, Y., Quinlan, K. G., Eisman, J. A., Nguyen, T. V., Center, J. R., Prince, R. L., Wilson, S. G., Zhu, K., Little, D. G. and North, K. N. 2011. alpha-Actinin-3 deficiency is associated with reduced bone mass in human and mouse. Bone 49, 790-798.   DOI   ScienceOn
3 Santiago, C., Ruiz, J. R., Muniesa, C. A., Gonzalez-Freire, M., Gomez-Gallego, F. and Lucia, A. 2010. Does the polygenic profile determine the potential for becoming a world-class athlete? Insights from the sport of rowing. Scand. J. Med. Sci. Sports 20, e188-94.   DOI   ScienceOn
4 Thomis, M. A., Huygens, W., Heuninckx, S., Chagnon, M., Maes, H. H., Claessens, A. L., Vlietinck, R., Bouchard, C. and Beunen, G. P. 2004. Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/ deletion genotype in responses of human muscle to strength training. Eur. J. Appl. Physiol. 92, 267-274.
5 Song, Y. H., Li, Y., Du, J., Mitch, N. Rosenthal, and Delafontaine, P. 2005. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J. Clin. Invest. 115, 451-458.   DOI
6 Soubrier, F., Wei, L., Hubert, C., Clauser, E., Alhenc-Gelas, F. and Corvol, P. 1993. Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications. J. Hypertens 11, 599-604.   DOI   ScienceOn
7 Taniwaki, H., Ishimura, E., Matsumoto, N., Emoto, E., Inaba, M. and Nishizawa, Y. 2001. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 24, 1653-1660.   DOI   ScienceOn
8 Tsianos, G. I., Evangelou, E., Boot, A., Zillikens, M. C., van Meurs, J. B., Uitterlinden, A. G. and Ioannidis, J. P. 2010. Associations of polymorphisms of eight muscle- or metabolism-related genes with performance in Mount Olympus marathon runners. J. Appl. Physiol. 108, 567-574.
9 Walsh, S., Liu, D., Metter, E. J., Ferrucci, L. and Roth, S. M. 2008. ACTN3 genotype is associated with muscle phenotypes in women across the adult age span. J. Appl. Physiol. 105, 1486-1491.   DOI   ScienceOn
10 Williams, A. G. and Folland, J. P. 2008. Similarity of polygenic profiles limits the potential for elite human physical performance. J. Physiol. 586, 113-121.   DOI
11 Yang, N., Garton, F. and North, K. 2009. Alpha-Actinin-3 and Performance. Med. Sport. Sci. 54, 88-101.   DOI
12 Ruiz, J. R., Arteta, D., Buxens, A., Artieda, M., Gomez-Gallego, F., Santiago, C., Yvert, T., Moran, M. and Lucia, A. 2010. Can we identify a power-oriented polygenic profile? J. Appl. Physiol. 108, 561-566.   DOI   ScienceOn
13 Rigat, B., Hubert, C., Corvol, P. and Soubrier, F. 1992. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20, 1433.
14 Rodriguez-Romo, G., Ruiz, J. R., Santiago, C., Fiuza-Luces, C., Gonzalez-Freire, M., Gomez-Gallego, F., Moran, M. and Lucia, A. 2010. Does the ACE I/D polymorphism, alone or in combination with the ACTN3 R577X polymorphism, influence muscle power phenotypes in young, non-athletic adults? Eur. J. Appl. Physiol. 110, 1099-1106.   DOI   ScienceOn
15 Roth, S. M., Walsh, S., Liu, D., Metter, E. J., Ferrucci, L. and Hurley, B. F. 2008. The ACTN3 R577X nonsense allele is under-represented in elite-level strength athletes. Eur. J. Hum. Genet. 16, 391-394.   DOI   ScienceOn
16 Ruiz, J. R., Fernandez del Valle, M., Verde, Z., Diez-Vega, I., Santiago, C., Yvert, T., Rodriguez-Romo, G., Gomez-Gallego, F., Molina, J. J. and Lucia, A. 2011. ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players. Scand. J. Med. Sci. Sports. 21, e34-41.   DOI   ScienceOn
17 Russell, S. T., Sanders, P. M. and Tisdale, M .J. 2006. Angiotensin II directly inhibits protein synthesis in murine myotubes. Cancer Lett. 231, 290-294.   DOI   ScienceOn
18 Sanders, P. M., Russell, S. T. and Tisdale, M. J. 2005. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia. Br. J. Cancer 93, 425-434.   DOI   ScienceOn
19 Santiago, C., Rodriguez-Romo, G., Gomez-Gallego, F., Gonzalez-Freire, M., Yvert, T., Verde, Z., Naclerio, F., Altmae, S., Esteve-Lanao, J. R., Ruiz, J. and Lucia, A. 2010. Is there an association between ACTN3 R577X polymorphism and muscle power phenotypes in young, non-athletic adults? Scan. J. Med.Sci. Sports 20, 771-778.   DOI   ScienceOn
20 MacArthur, D. G., Seto, J. T., Raftery, J. M., Quinlan, K. G., Huttley, G. A., Hook, J. W., Lemckert, F. A., Kee, A. J., Edwards, M. R., Berman, Y., Hardeman, E. C., Gunning, P. W., Easteal, S., Yang, N. and North, K. N. 2007. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat. Genet. 39, 1261-1265.   DOI   ScienceOn
21 Montgomery, H., Clarkson, P., Barnard, M., Bell, J., Brynes, A., Dollery, C., Hajnal, J., Hemingway, H., Mercer, D., Jarman, P., Marshall, R., Prasad, K., Rayson, M., Saeed, N., Talmud, P., Thomas, L., Jubb, M., World, M. and Humphries, S. 1999. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 353, 541-545.   DOI   ScienceOn
22 Mori, S. and Tokuyama, K. 2007. Variation in ACE activity affects myogenic differentiation in C2C12 cells. Biochem. Biophys. Res. Commun. 353, 369-375.   DOI   ScienceOn
23 North, K. N., Yang, N., Wattanasirichaigoon, D., Mills, M., Easteal, S. and Beggs, A. H. 1999. A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat. Genet. 21, 353-354.   DOI   ScienceOn
24 Papadimitriou, I. D., Papadopoulos, C., Kouvatsi, A. and Triantaphyllidis, C. 2008. The ACTN3 gene in elite Greek track and field athletes. Int. J. Sports Med. 29, 352-355.   DOI   ScienceOn
25 Powers, S. K. and Dodd, S. L. 2009. Total Fitness and Wellness. Pearson Benjamin Cummings, San Francisco.
26 Puthucheary, Z., Skipworth, J. R., Rawal, J., Loosemore, M., Van Someren, K. and Montgomery, H. E. 2011. The ACE gene and human performance: 12 years on. Sports Med. 41, 433-448.   DOI   ScienceOn
27 Puthucheary, Z., Skipworth, J. R., Rawal, J., Loosemore, M., Van Someren, K. and Montgomery, H. E. 2011. Genetic influences in sport and physical performance. Sports Med. 41, 845-859.   DOI   ScienceOn
28 Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. and Soubrier, F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343-1346.   DOI   ScienceOn
29 Henriksen, E. J. and Jacob, S. 2003. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. J. Cell Physiol. 196, 171-179.   DOI   ScienceOn
30 Hagberg, J. M., Rankinen, T., Loos, R. J., Perusse, L., Roth, S. M., Wolfarth, B. and Bouchard, C. 2011. Advances in exercise, fitness, and performance genomics in 2010. Med. Sci. Sports Exerc. 43, 743-752.
31 Hughes, D. C., Day, S. H., Ahmetov, I. I. and Williams, A. G. 2011. Genetics of muscle strength and power: polygenic profile similarity limits skeletal muscle performance. J. Sports Sci. 29, 1425-1434.   DOI   ScienceOn
32 Kasikcioglu, E., Kayserilioglu, A., Ciloglu, F., Akhan, H., Oflaz, H., Yildiz, S. and Peker, I. 2004. Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes. Heart Vessels 19, 287-293.   DOI   ScienceOn
33 Kim, C. H., Cho, J. Y., Jeon, J. Y., Koh, Y. G., Kim, Y. M., Kim, H. J., Park, M., Um, H. S. and Kim, C. 2010. ACE DD genotype is unfavorable to Korean short-term muscle power athletes. Int. J. Sports Med. 31, 65-71.   DOI
34 Koch, W., Latz, W., Eichinger, M., Ganser, C., Schomig, A. and Kastrati, A. 2005. Genotyping of the angiotensin I-converting enzyme gene insertion/deletion polymorphism by the TaqMan method. Clin. Chem. 51, 1547-1549.   DOI   ScienceOn
35 Koh, T. J. and Tidball, J. G. 1999. Nitric oxide synthase inhibitors reduce sarcomere addition in rat skeletal muscle. J. Physiol. 519 Pt 1, 189-196.   DOI   ScienceOn
36 Longhurst, J. C. and Stebbins, C. L. 1997. The power athlete. Cardiol. Clin. 15, 413-429.   DOI   ScienceOn
37 Macarthur, D. G. and North, K. N. 2005. Genes and human elite athletic performance. Hum. Genet. 116, 331-339.   DOI   ScienceOn
38 MacArthur, D. G. and North, K. N. 2004. A gene for speed? The evolution and function of alpha-actinin-3. Bioessays 26, 786-795.   DOI   ScienceOn
39 Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., ap Rhys, C.M., Holm, T. M., Loeys, B. L., Ramirez, F., Judge, D. P., Ward, C. W. and Dietz, H. C. 2007. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13, 204-210.   DOI   ScienceOn
40 Brink, M., Wellen, J. and Delafontaine, P. 1996. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J. Clin. Invest. 97, 2509-2516.   DOI   ScienceOn
41 Delmonico, M. J., Kostek, M. C., Doldo, N. A., Hand, B. D., Walsh, S., Conway, J. M., Carignan, C. R., Roth, S. M. and Hurley, B. F. 2007. Alpha-actinin-3 (ACTN3) R577X polymorphism influences knee extensor peak power response to strength training in older men and women. J. Gerontol. A Biol. Sci. Med. Sci. 62, 206-212.   DOI   ScienceOn
42 Druzhevskaya, A. M., Ahmetov, I. I., Astratenkova, I. V. and Rogozkin. V. A. 2008. Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur. J. Appl. Physiol. 103, 631-634.   DOI   ScienceOn
43 Dzau, V. J., Gibbons, G. H. and Pratt, R. E. 1991. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 18, II100-105.   DOI
44 Eynon, N., Alves, A. J., Meckel, Y., Yamin, C., Ayalon, M., Sagiv, M. and Sagiv, M. 2010. Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/ sprint performance? Metabolism 59, 861-865.   DOI   ScienceOn
45 Fagard, R. H. 1997. Impact of different sports and training on cardiac structure and function. Cardiol. Clin. 15, 397-412.   DOI   ScienceOn
46 Frey, N., Richardson, J. A. and Olson, E. N. 2000. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl. Acad. Sci. USA 97, 14632-14637.   DOI   ScienceOn
47 Brink, M., Price, S. R., Chrast, J., Bailey, J. L., Anwar, A., Mitch, W. E. and Delafontaine, P. 2001. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 142, 1489-1496.   DOI   ScienceOn
48 Gomez-Gallego, F., Santiago, C., Gonzalez-Freire, M., Muniesa, C. A., Fernandez Del Valle, M., Perez, M., Foster, C. and Lucia, A. 2009. Endurance performance: genes or gene combinations? Int. J. Sports Med. 30, 66-72.   DOI   ScienceOn
49 Bouchard, C., Malina, R. and Perusse, L. 1997. Genetics of Fitness and Physical Performance. Human Kinetics, Champaign, Illinois.